0001235802-19-000139.txt : 20191206
0001235802-19-000139.hdr.sgml : 20191206
20191206165151
ACCESSION NUMBER: 0001235802-19-000139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191206
DATE AS OF CHANGE: 20191206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wallace Steven P.
CENTRAL INDEX KEY: 0001763512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35065
FILM NUMBER: 191273626
MAIL ADDRESS:
STREET 1: 1023 CHERRY ROAD
CITY: MEMPHIS
STATE: TN
ZIP: 38117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wright Medical Group N.V.
CENTRAL INDEX KEY: 0001492658
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 980509600
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: PRINS BERNHARDPLEIN 200
CITY: AMSTERDAM
STATE: P7
ZIP: 1097JB
BUSINESS PHONE: 901-867-4317
MAIL ADDRESS:
STREET 1: 1023 CHERRY ROAD
CITY: MEMPHIS
STATE: TN
ZIP: 38117
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier N.V.
DATE OF NAME CHANGE: 20110201
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier B.V.
DATE OF NAME CHANGE: 20100524
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-12-05
0
0001492658
Wright Medical Group N.V.
WMGI
0001763512
Wallace Steven P.
1023 CHERRY ROAD
MEMPHIS
TN
38117
0
1
0
0
President, International
Ordinary Shares, par value EUR 0.03 per share
2019-12-05
4
M
0
7634
26.81
A
21649
D
Ordinary Shares, par value EUR 0.03 per share
2019-12-05
4
M
0
5412
27.86
A
27061
D
Ordinary Shares, par value EUR 0.03 per share
2019-12-05
4
M
0
4176
24.49
A
31237
D
Ordinary Shares, par value EUR 0.03 per share
2019-12-05
4
S
0
17222
29.6001
D
14015
D
Stock Option (right to buy)
26.81
2019-12-05
4
M
0
7634
0
D
2027-02-16
Ordinary Shares
7634
3482
D
Stock Option (right to buy)
27.86
2019-12-05
4
M
0
5412
0
D
2027-07-25
Ordinary Shares
5412
3875
D
Stock Option (right to buy)
24.49
2019-12-05
4
M
0
4176
0
D
2028-07-24
Ordinary Shares
4176
8360
D
Exercise and sale of vested stock options in connection with 280G tax planning
Includes 1,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,232 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,939 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.605, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
This option vested with respect to 25% of the shares on February 16, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
/s/Marija Nelson, attorney-in-fact
2019-12-06